1-methylhexyl methanesulfonate | 62078-83-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: 1-methylhexyl methanesulfonate
• 英文别名: 2-heptyl methanesulfonate；(+/-)-methanesulfonic acid-(-1-methyl-hexyl ester)；(+/-)-Methansulfonsaeure-(-1-methyl-hexylester)；(1-Methyl-hexyl)-mesylat；Heptan-2-yl methanesulfonate
• CAS: 62078-83-5
• 化学式: C₈H₁₈O₃S
• 分子量: 194.295
• InChiKey: ZFLRDIUZHADLSV-UHFFFAOYSA-N

物化性质

• 沸点：
  77-79 °C(Press: 1 Torr)
• 密度：
  1.027 g/cm3(Temp: 25 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  12
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  51.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-methylhexyl methanesulfonate 在 氢氧化钾 、 双氧水 作用下， 生成 2-氢过氧基庚烷
  参考文献：
  名称：

  Peroxides. I. n-Alkyl Hydroperoxides

  摘要：

  DOI：

  10.1021/ja01640a036
• 作为产物：
  描述：

  2-庚醇 、 甲基磺酰氯 在 吡啶 作用下， 生成 1-methylhexyl methanesulfonate
  参考文献：
  名称：

  Peroxides. I. n-Alkyl Hydroperoxides

  摘要：

  DOI：

  10.1021/ja01640a036

文献信息

• [EN] DNA-DEPENDENT PROTEIN KINASE INHIBITOR<br/>[FR] INHIBITEUR DE PROTÉINE KINASE DÉPENDANTE DE L'ADN
  申请人：DIZAL JIANGSU PHARMACEUTICAL CO LTD

  公开号：WO2020238900A1

  公开（公告）日：2020-12-03

  Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, that are useful as DNA-PK inhibitors. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula (I), and methods of using such compounds or compositions to treat DNA-PK related disorder (e.g., cancer).

  本文披露了式（I）的化合物及其药学上可接受的盐，这些化合物可用作DNA-PK抑制剂。还披露了包含一种或多种式（I）化合物的药物组合物，以及使用这些化合物或组合物来治疗DNA-PK相关疾病（例如癌症）的方法。
• Synthesis of 5<i>H</i>-[1]benzopyrano[4,3-<i>b</i>]pyridin-5-ones containing an azacannabinoidal structure
  作者：D. Heber、Th. Berghaus

  DOI：10.1002/jhet.5570310610

  日期：1994.11

  Starting from 7-alkoxy-4-aminocoumarins 5,6,8,12, and 13 as key intermediates, this paper describes two different methods for the preparation of azacannabinoidal 5H[1]benzopyrano[4,3-b]pyridin-5-ones 24–27, 38, and 39 containing typical structural requirements for ZNS activity. First, Michael addition of 6 and 8 to the double bonds of alkyl vinyl ketones 14 and 15 resulted in a mixture of tetrahydropyridines

  从7-烷氧基-4-氨基香豆素5,6,8,12和13为关键中间体开始，本文描述了两种制备氮杂大麻素5 H [1]苯并吡喃并[4,3 - b ]吡啶5的方法。 -酮24-27，38和39包含用于ZNS活性典型结构要求。首先，在烷基乙烯基酮14和15的双键上加成6和8，得到四氢吡啶24-27和稠合吡啶20-23的混合物，后者被氰基硼氢化钠还原而得到目标化合物24–27。第二，吡啶环的封闭是通过Vilsmeier乙酰化和甲酰化的结合来完成的，从而产生稠合的4-氯吡啶31-33，然后还原。
• Nickel-catalyzed reductive coupling of arylcarboxylic acid 2-pyridyl esters with alkyl methanesulfonates: access to alkyl aryl ketones
  作者：Hang Yu、Zhong-Xia Wang

  DOI：10.1039/d3ob00293d

  日期：——

  Alkyl aryl ketones were synthesized via a nickel-catalyzed reductive coupling reaction of arylcarboxylic acid (2-pyridyl)esters with primary and secondary alkyl methanesulfonates under mild reaction conditions. This method suits a wide range of substrates and shows good compatibility with functional groups.

  在温和的反应条件下，通过芳基羧酸（2-吡啶基）酯与甲磺酸伯和仲烷基酯的镍催化还原偶联反应合成烷基芳基酮。该方法适用于广泛的底物，并显示出与官能团的良好相容性。
• 9,11-Epoxy-9-homo-14-oxaprosta-5-enoic acid derivatives. Novel inhibitors of fatty acid cyclooxygenase
  作者：Steven E. Hall、Wen Ching Han、Martin F. Haslanger、Don N. Harris、Martin L. Ogletree

  DOI：10.1021/jm00161a032

  日期：1986.11

  A novel bicyclic prostaglandin analogue, [1R-[l alpha,2 beta (5Z),3 beta,4 alpha]]-7-[3-[(hexyloxy)methyl]- 7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (1), and cogeners were found to be potent inhibitors of fatty acid cyclooxygenase. Compound 1 was the only stereoisomer out of eight possible structures that was active. Ether 1 was 20 times more potent than indomethacin (IND) in inhibiting arachidonic acid (AA) induced aggregation of human platelet-rich plasma. Compound 1 was also more potent than IND in several in vivo assays, AA-induced sudden death in the conscious mouse (2 times) and AA-induced bronchoconstriction in the anesthetized guinea pig (16-45 times).
• HETEROCYCLIC COMPOUND
  申请人：Cardurion Pharmaceuticals, LLC

  公开号：EP3600327A1

  公开（公告）日：2020-02-05